Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Lugano
Clinical trial register · Switzerland

Clinical Trials in Lugano, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Switzerland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2249 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:18 UTC
2249
Studies in scope
all four open statuses
1364
Recruiting now
open to new participants
528
Lead sponsors
across recruiting studies
Top sites
Zurich 739 Bern 722 Basel 636 Geneva 406 Lausanne 394
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Ente Ospedaliero Cantonale, Bellinzona13 University Hospital, Basel, Switzerland10 Insel Gruppe AG, University Hospital Bern7 Cardiocentro Ticino6 Merck Sharp & Dohme LLC6 Fondazione Epatocentro Ticino5 Hoffmann-La Roche5 University Hospital, Geneva5 AbbVie4 Medtronic4 Novartis Pharmaceuticals4 Christian Candrian4 Amgen3 Ipsen2 LeMaitre Vascular2 Alain Kaelin2 Università Vita-Salute San Raffaele1 Biotronik AG1 IBSA Farmaceutici Italia Srl1 Antonio Leidi1 Viatris Innovation GmbH1 Lugano Istituti Sociali1 Vascutek Ltd.1 Orchestra BioMed, Inc1 Fondazione IRCCS Policlinico San Matteo di Pavia1 Show all 65
Site location
Zurich739 Bern722 Basel636 Geneva406 Lausanne394 Sankt Gallen272 Lucerne152 Bellinzona148 Aarau136 Lugano131 Chur99 Baden81 Winterthur81 Fribourg72 Liestal35 Olten32 Sion24 Frauenfeld22 Thun19 Münsterlingen15 Nottwil15 Biel14 Neuchâtel13 Solothurn12 Meyrin12 Show all 151
All 151 locations
Target enrolment
to

Trials with a site in Lugano

131 of 2249 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Switzerland
Start
Not yet open
Acoustic Stimulation to Study and Modulate Sleepwalking and Related Arousal Disorders
NCT07754838NREM Parasomnias, Sleepwalking, Sleep Terrors, Confusional Arousals
Anna Castelnovo
Not applicable
50
Lugano
2027-02-01
Not yet open
Eva Koetsier MD PhD
Not applicable
140
Lugano
2027-01-01
Recruiting
AbbVie
Phase 3
531
Basel Town, Geneva, Lausanne, Lugano
2026-07-02
Recruiting
Sleep, Mental Fatigue, and Performance in Students
NCT07644611Mental Fatigue, Sleep and Circadian Problems
L.U.de.S. Sagl
Observational
30
Lugano
2026-07-01
Recruiting
Merck Sharp & Dohme LLC
Phase 2
750
Basel, Sankt Gallen, Lugano, Geneva, Lucerne
2026-06-30
Not yet open
EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study)
NCT07267624VAP - Ventilator Associated Pneumonia, Antibiotic, Antibiotic Stewardship, Antibiotic Prescribing for Acute Respiratory-tract Infections
University Hospital, Geneva
Not applicable
170
Geneva, Lausanne, Lugano, Neuchâtel, Sion
2026-06-05
Not yet open
Clinica ARS Medica
Not applicable
15
Gravesano, Lugano
2026-06-01
Recruiting
Ipsen
Phase 3
350
Basel, Bern, Lugano, Zurich
2026-05-14
Active, closed
Lugano Istituti Sociali
Not applicable
219
Lugano
2026-05-01
Recruiting
Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.
NCT07582835Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndromes, Antiplatelet Therapy
DrugsPrasugrel·Ticagrelor·Clopidogrel
Cardiocentro Ticino
Phase 3
355
Lugano
2026-04-20
Recruiting
Visugromab in Cachexia International Trial
NCT07112196Cancer-associated Cachexia
DrugVisugromab
CatalYm GmbH
Phase 2/3
518
Aarau, Basel, Bellinzona, Lugano, Sankt Gallen, Zurich
2026-04-16
Recruiting
Prouse Giorgio
Observational
125
Lucerne, Lugano
2026-03-18
Recruiting
Ente Ospedaliero Cantonale, Bellinzona
Not applicable
84
Lugano
2026-02-03
Recruiting
Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement
NCT07278726ALND, Sentinel Lymph Node Biopsy (SLNB), Targeted Axillary Dissection (TAD)
European Institute of Oncology
Observational
150
Lugano
2026-01-28
Active, closed
CSL Behring
Phase 2
84
Bern, Lausanne, Lugano
2026-01-22
Recruiting
Mild TBI in the Emergency Department
NCT07021118Emergency Departments
Mario Negri Institute for Pharmacological Research
Observational
2,500
Lugano
2026-01-21
Recruiting
University Hospital, Basel, Switzerland
Not applicable
18,000
Basel, Lausanne, Aarau, Baden, Geneva, Lucerne, Lugano, Sankt Gallen
2025-12-03
Active, closed
Hoffmann-La Roche
Phase 3
1,060
Bern, Geneva, Lausanne, Lugano
2025-11-12
Recruiting
Effect of Virtual Reality on the Need of Premedication Before Surgery
NCT07450456Anxiety, Premedication, Surgery, Virtual Reality
Ente Ospedaliero Cantonale, Bellinzona
Not applicable
40
Lugano
2025-11-11
Recruiting
Comparative Intra-procedural Evaluation of Farapulse and FARAWAVE Nav Catheters
NCT07130773Atrial Fibrillation (AF), Atrial Fibrillation Ablation, Pulsed Field Ablation
Cardiocentro Ticino
Not applicable
58
Lugano
2025-11-10
Recruiting
Alain Kaelin
Not applicable
30
Lugano
2025-11-06
Recruiting
Marc Blondon
Phase 3
9,200
Baden, Basel, Bern, Geneva, Lausanne, Lucerne, Lugano, Neuchâtel
2025-10-15
Recruiting
AbbVie
Observational
2,795
Aarau, Basel Town, Geneva, Lucerne, Zurich, Bellinzona, Lugano, Orsières
2025-09-02
Recruiting
Fondazione Epatocentro Ticino
Phase 2
10
Lugano
2025-09-01
Recruiting
Ticino Artificial InTelligence integrAtioN for Occlusion Myocardial Infarction
NCT07077057Myocardial Infarction (MI), Acute Coronary Syndrome (ACS)
Cardiocentro Ticino
Not applicable
500
Lugano
2025-08-23
Recruiting
An Observational Study to Evaluate Safety, Performance, and Clinical Benefit of BeFlow
NCT07010354Iliac Artery Stenosis, Iliac Artery Occlusion
Bentley InnoMed GmbH
Observational
100
Lugano
2025-08-08
Active, closed
Boston Scientific Corporation
Observational
550
Lugano, Zurich
2025-07-30
Active, closed
Amgen
Phase 3
12,800
Basel, Bern, Geneva, Lausanne, Lugano, Zurich
2025-07-25
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Basel, Lausanne, Lucerne, Lugano, Sankt Gallen, Zurich
2025-07-22
Recruiting
Teleflex
Not applicable
150
Basel, Lugano
2025-07-18
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Basel, Bern, Geneva, Lausanne, Lucerne, Lugano, Sankt Gallen
2025-06-25
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
110
Aarau, Basel, Bern, Lucerne, Lugano, Sankt Gallen
2025-06-01
By invitation
Novo Nordisk A/S
Observational
1,250
Bern, Geneva, Lucerne, Lugano, Neuchâtel, Olten, Sankt Gallen, Zurich
2025-05-01
Active, closed
Merck Sharp & Dohme LLC
Phase 2
150
Basel, Bern, Geneva, Lugano
2025-04-14
Not yet open
Ticin Pilot Study: Sirolimus-Eluting Balloon for Stabilization and Regression of Non-Obstructive Coronary Plaques.
NCT06928883Coronary Arterial Disease (CAD), Vulnerable Coronary Plaques, Multivessel Coronary Artery Disease, Coronary Vessel
DrugGDMT
Cardiocentro Ticino
Not applicable
24
Lugano
2025-04
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 4
906
Baden, Basel, Bern, Biel, Geneva, Lausanne, Lucerne, Lugano
2025-03-14
Recruiting
Swiss Federal Institute of Technology
Not applicable
100
Brissago, Lugano
2025-03-04
Recruiting
Middle Meningeal Artery Embolization for Chronic Subdural Hematomas (STORMM)
NCT06163547Chronic Subdural Hematomas, Cerebral Compression Due to Injury
University Hospital, Geneva
Not applicable
180
Geneva, Lugano
2025-02-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Baden, Sankt Gallen, Bellinzona, Lugano
2025-01-27
Active, closed
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
NCT06700343Relapsing-remitting Multiple Sclerosis (RRMS)
DrugOcrelizumab
Amgen
Phase 3
152
Bern, Lugano
2025-01-13
Recruiting
Biotronik AG
Observational
200
Lugano
2024-12-19
Recruiting
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
NCT06689956FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Stage IA1 Endometrial Cancer FIGO 2023, Stage IA2 Endometrial Cancer FIGO 2023
Mayo Clinic
Observational
212
Lugano
2024-12-04
Active, closed
AbbVie
Observational
1,314
Reinach, Bad Zurzach, Lausanne, Zollikon, Zurich, Lugano, Sion, Bern
2024-11-26
Recruiting
Antonio Leidi
Not applicable
222
Geneva, Bern, Fribourg, Lugano
2024-10-22
Recruiting
Antonio Bellasi
Observational
30
Lugano
2024-10-12
Recruiting
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NCT06528314NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
DrugEfruxifermin
Akero Therapeutics, Inc
Phase 3
2,150
Olten, Lugano, Bern, Sankt Gallen, Zurich
2024-10-04
Active, closed
Ente Ospedaliero Cantonale, Bellinzona
Observational
70
Lugano
2024-10-03
Recruiting
Ente Ospedaliero Cantonale, Bellinzona
Not applicable
140
Lugano
2024-09-01
Active, closed
Cardiovascular and Interventional Radiological Society of Europe
Observational
400
Lugano, Winterthur
2024-07-15
Recruiting
University Hospital, Basel, Switzerland
Phase 2
75
Basel, Geneva, Lugano, Zurich
2024-06-06
Recruiting
SASL Swiss Cirrhosis Cohort
NCT06092385Liver Cirrhosis
University Hospital, Basel, Switzerland
Observational
3,000
Lugano, Basel, Bern, Geneva, Lausanne, Sankt Gallen, Zurich
2024-06-04
Active, closed
The OPBC-07/microNAC Study
NCT06529302Breast Cancer
University Hospital, Basel, Switzerland
Observational
2,000
Baden, Basel, Bern, Lucerne, Lugano, Sankt Gallen, Winterthur, Zurich
2024-05-15
Recruiting
Minimally Invasive Coronary Artery Bypass Supported by Cangrelor
NCT07514962Coronary Artery Disease, Antiplatelet Therapy, Minimally Invasive Coronary Revascularization Surgery
Cardiocentro Ticino
Observational
30
Lugano
2024-05-12
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
482
Lugano, Lausanne, Basel, Bern, Geneva, Lucerne, Sankt Gallen, Zurich
2024-05-01
Active, closed
Ente Ospedaliero Cantonale, Bellinzona
Not applicable
25
Lugano
2024-04-23
Recruiting
Effect of Virtual Reality on Patient's Comfort During Cardiac Electronic Device Implantation.
NCT06346132Virtual Reality, Medical Device, Local Anesthesia, Pain
Schlotterbeck Hervé
Not applicable
150
Lugano
2024-03-29
Recruiting
Novartis Pharmaceuticals
Phase 2
502
Basel, Geneva, Lausanne, Lugano, Zurich
2024-03-07
Active, closed
Bristol-Myers Squibb
Phase 4
63
Lucerne, Lugano, Geneva, Zürich (de)
2024-01-24
Recruiting
Insel Gruppe AG, University Hospital Bern
Observational
2,800
Aarau, Basel, Bern, Fribourg, Geneva, Lausanne, Lucerne, Lugano
2024-01-01
Recruiting
University Hospital, Basel, Switzerland
Not applicable
200
Basel, Bern, Geneva, Lausanne, Lucerne, Lugano, Sankt Gallen, Sion
2024-01-01
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT06059638Hypertension, Hypertension, Systolic, Hypertension, Essential
Orchestra BioMed, Inc
Not applicable
316
Basel, Bern, Geneva, Lugano
2023-12-27
Recruiting
Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
NCT05955365Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation, P2Y12 Inhibitor
DrugsDOAC·Aspirin
Insel Gruppe AG, University Hospital Bern
Phase 4
3,010
Lugano, Basel, Bern, Geneva, Zurich
2023-12-18
By invitation
B-free Multistage Trial
NCT06037564HIV, Drug Resistance, Drug Drug Interaction
Insel Gruppe AG, University Hospital Bern
Phase 4
210
Aarau, Basel, Bern, Geneva, Lausanne, Lugano, Sankt Gallen, Zurich
2023-11-13
Active, closed
Enlighten Study: The EV-ICD Post Approval Registry
NCT06048731Ventricular Arrhythmia, Tachycardia
Medtronic
Observational
1,000
Basel, Bern, Lausanne, Lugano, Zurich
2023-09-01
Recruiting
Fondazione Epatocentro Ticino
Observational
300
Lugano
2023-07-19
Recruiting
IBSA Farmaceutici Italia Srl
Not applicable
50
Lugano
2023-07-17
Recruiting
ClassIntra® for Better Outcomes in Surgery - CIBOSurg
NCT05818332Perioperative Patient Safety
University Hospital, Basel, Switzerland
Observational
1,800
Basel, Bern, Chur, Geneva, Lausanne, Lucerne, Lugano, Zurich
2023-07-17
Recruiting
Total Hip Arthroplasty: Fluoroscopy vs Freehand
NCT05653687Intraoperative Fluoroscopy
Ente Ospedaliero Cantonale, Bellinzona
Not applicable
84
Lugano
2023-05-22
Active, closed
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
NCT05705973Cardiovascular Disease, Coronary Artery Occlusion, Ischemic Heart Disease
Terumo Europe N.V.
Observational
3,000
Basel, Lucerne, Lugano
2023-04-25
Recruiting
Takeda
Phase 2/3
500
Barmelweid, Lugano, Bern
2023-04-05
Recruiting
University Hospital, Geneva
Observational
400
Bellinzona, Bern, Geneva, Lausanne, Lugano, Sankt Gallen, Zurich
2023-04-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
641
Basel, Geneva, Sankt Gallen, Zurich, Lugano, Bern
2023-03-17
Active, closed
Ente Ospedaliero Cantonale, Bellinzona
Not applicable
70
Lugano
2023-03-15
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Basel, Bern, Geneva, Lucerne, Lugano
2023-03-09
Recruiting
Ente Ospedaliero Cantonale, Bellinzona
Not applicable
20
Lugano
2023-03-02
Recruiting
Cardiocentro Ticino
Phase 4
130
Lugano
2023-02-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
553
Basel, Geneva, Lausanne, Zurich, Lugano, Bern
2023-02-20
Active, closed
University Hospital, Basel, Switzerland
Not applicable
920
Basel, Aarau, Bern, Geneva, Lausanne, Lugano, Sankt Gallen, Zurich
2023-02-05
Recruiting
Ente Ospedaliero Cantonale, Bellinzona
Not applicable
122
Lugano
2023-01-19
Recruiting
LeMaitre Vascular
Not applicable
112
Lugano
2023-01-11
Active, closed
Calmy Alexandra
Phase 4
225
Basel, Bern, Geneva, Sankt Gallen, Lausanne, Zurich, Lugano
2022-12-14
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
Aarau, Basel, Bern, Binningen, Geneva, Lausanne, Lucerne, Lugano
2022-11-21
Active, closed
AbbVie
Observational
400
Zurich, Lugano, Bern
2022-10-20
Active, closed
Dentsply Sirona Implants and Consumables
Not applicable
139
Lugano
2022-09-22
By invitation
Ottawa Heart Institute Research Corporation
Observational
3,500
Bern, Lugano, Zurich
2022-09-01
Active, closed
Biogen
Phase 2
416
Lugano, Biel/Bienne, Geneva, Sankt Gallen
2022-08-24
Active, closed
Novartis Pharmaceuticals
Phase 3
610
Geneva, Lugano
2022-07-08
Active, closed
Hoffmann-La Roche
Phase 3
1,300
Basel, Lugano
2022-05-03
Active, closed
Ente Ospedaliero Cantonale, Bellinzona
Observational
42
Lugano
2022-04-13
Active, closed
DreaMS - Validation Study 1
NCT05009160Multiple Sclerosis
Research Center for Clinical Neuroimmunology and Neuroscience Basel
Observational
300
Aarau, Lausanne, Lugano, Sankt Gallen, Zurich, Basel
2022-03-30
Recruiting
LeMaitre Vascular
Not applicable
112
Lugano
2022-01-11
Recruiting
Christian Candrian
Not applicable
80
Lugano
2021-12-29
Recruiting
Ente Ospedaliero Cantonale, Bellinzona
Phase 4
110
Lugano
2021-12-10
Active, closed
NATURE (EnVast as an Adjunct PPCI in Subjects Presenting With STEMI)
NCT04969471Segment Elevation Myocardial Infarction (STEMI)
Vesalio
Not applicable
148
Bern, Geneva, Lucerne, Lugano
2021-12-09
Active, closed
University Hospital, Basel, Switzerland
Not applicable
543
Aarau, Basel, Bern, Geneva, Lausanne, Lucerne, Lugano, Sankt Gallen
2021-12-09
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2
333
Lugano, Zurich
2021-09-22
Active, closed
Merck Sharp & Dohme LLC
Phase 3
2,000
Basel, Geneva, Sankt Gallen, Zurich, Lugano, Bern
2021-09-15
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Basel, Bern, Lugano, Sankt Gallen
2021-08-14
Active, closed
Abiomed Inc.
Not applicable
1,252
Lugano, Bern, Lucerne
2021-04-13
Recruiting
Ente Ospedaliero Cantonale, Bellinzona
Observational
1,500
Lugano
2021-04-06
Recruiting
Giulia Manzini
Phase 3
210
Aarau, Basel, Lucerne, Lugano, Sankt Gallen
2021-03-25
Active, closed
Hoffmann-La Roche
Phase 3
746
Bern, Lugano
2021-03-17
Active, closed
Hoffmann-La Roche
Phase 3
864
Basel, Bern, Lugano
2020-11-26
Recruiting
Christian Candrian
Not applicable
96
Lugano
2020-09-28
Active, closed
Ipsen
Phase 3
161
Bern, Lugano
2020-09-24
Recruiting
Christian Candrian
Phase 4
74
Lugano
2020-09-09
Recruiting
Christian Candrian
Phase 4
159
Lugano
2020-07-01
Recruiting
Ente Ospedaliero Cantonale, Bellinzona
Not applicable
100
Lugano
2020-04-28
Recruiting
Terumo Aortic Global Endovascular Registry
NCT04246463Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Surgery
Vascutek Ltd.
Observational
1,000
Lucerne, Lugano
2019-12-17
Active, closed
ReFlow Medical, Inc.
Not applicable
100
Lugano
2019-07-11
Recruiting
Swiss Severe Asthma Register
NCT03984253Severe Asthma
Prof. Dr. Jörg Leuppi
Observational
600
Liestal, Bern, Chur, Davos, Geneva, Lausanne, Lugano, Sankt Gallen
2019-05-13
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Bern, Lugano, Zurich
2019-03-28
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Basel, Lugano
2018-12-28
Recruiting
Swiss Registry for Neuromuscular Disorders
NCT05102916SMA, DMD, BMD, IMD
University of Bern
Observational
2,000
Aarau, Bellinzona, Lugano, Lausanne, Basel, Bern, Geneva, Lucerne
2018-06-20
Recruiting
Alain Kaelin
Phase 3
48
Bern, Lausanne, Lugano, Sankt Gallen, Zurich
2018-02-21
Recruiting
In-hospital Stellate Ganglion Block for Arrhythmic Storm
NCT05720936Arrhythmic Storm, Electrical Storm, Ventricular Fibrillation, Ventricular Tachycardia
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
500
Lugano
2017-11-07
Recruiting
Swiss Primary Sclerosing Cholangitis Cohort Study
NCT03146936Cholangitis, Sclerosing, PSC, Primary Sclerosing Cholangitis (PSC)
Fondazione Epatocentro Ticino
Observational
120
Lugano, Basel, Bern, Bülach, Chur, Geneva, Lausanne, Liestal
2017-02-28
Recruiting
Swiss Autoimmune Hepatitis Cohort Study
NCT03146884Hepatitis, Autoimmune, Autoimmune Hepatitis
Fondazione Epatocentro Ticino
Observational
500
Lugano, Basel, Bern, Chur, Geneva, Lausanne, Liestal, Lucerne
2017-02-16
Recruiting
Swiss Primary Biliary Cholangitis Cohort Study
NCT03146910PBC, Primary Biliary Cholangitis
Fondazione Epatocentro Ticino
Observational
500
Lugano, Basel, Bern, Bülach, Chur, Geneva, Lausanne, Liestal
2017-02-15
Active, closed
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
NCT02710435Angina Pectoris, Angina Pectoris, Stable, Chronic Stable Angina
Shockwave Medical, Inc.
Observational
400
Basel, Fribourg, Geneva, Lugano
2016-03
Active, closed
WiCS-LV Post Market Surveillance Registry
NCT02610673Cardiac Resynchronization Therapy
EBR Systems, Inc.
Observational
100
Lugano
2016-02-08
Active, closed
Medtronic
Observational
3,100
Basel, Bern, Fribourg, Geneva, Lausanne, Lugano, Zurich
2015-07
Recruiting
Surgery for Recurrent Glioblastoma
NCT02394626Glioblastoma
Insel Gruppe AG, University Hospital Bern
Phase 2
120
Basel, Bern, Lausanne, Lugano
2015-05-01
Active, closed
Ischaemic PReconditioning In Non Cardiac surgEry
NCT02427867Myocardial Ischemia, Surgery
Università Vita-Salute San Raffaele
Not applicable
1,217
Lugano
2015-04
Recruiting
Swiss Trauma Registry
NCT03526029Trauma, Multiple, Trauma
University Hospital, Basel, Switzerland
Observational
2,000
Aarau, Basel, Bern, Chur, Geneva, Lausanne, Lucerne, Lugano
2015-01-01
By invitation
Juvenile Inflammatory Rheumatism (JIR) Cohorte
NCT02377245Arthritis, Juvenile Rheumatoid
Michaël Hofer
Observational
15,000
Lausanne, Aarau, Basel, Bellinzona, Chur, Lucerne, Lugano, Sankt Gallen
2014-01
Recruiting
Swiss Multiple Sclerosis Cohort-Study
NCT02433028Multiple Sclerosis
University Hospital, Basel, Switzerland
Observational
1,200
Aarau, Basel, Bern, Geneva, Sankt Gallen, Lausanne, Lugano, Zurich
2012-06
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Basel, Bern, Fribourg, Geneva, Lausanne, Lugano, Meyrin, Morges
2012-01
Recruiting
Swiss Study on Subarachnoid Hemorrhage
NCT03245866Subarachnoid Hemorrhage, Intracranial Aneurysm
University Hospital, Geneva
Observational
5,000
Aarau, Geneva, Sankt Gallen, Basel, Bern, Lausanne, Lucerne, Lugano
2009-01-01
Recruiting
International Registry of Accidental Hypothermia
NCT06200285Accidental Hypothermia
University Hospital, Geneva
Observational
500
Chur, Geneva, Lugano, Zurich
2008-10-01
Recruiting
Medtronic
Observational
20,000
Basel, Bern, Fribourg, Geneva, Lausanne, Lugano, Zurich
1983-01
Rows per page Showing 1–131 of 131
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swiss investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-switzerland/city/lugano

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Switzerland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,249 studies in total at the last sync on 12 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 131 of those studies with a site in Lugano.

How many clinical trials are recruiting in Lugano?

77 of the 131 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:18 UTC sync. A further 5 have not yet opened recruitment, 44 are active but closed to new participants, and 5 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lugano), 131 studies
PhaseStudiesRecruitingShare
Observational462935.1%
Not applicable402530.5%
Phase 3251019.1%
Phase 2956.9%
Phase 4966.9%
Phase 2/3221.5%

Most active sponsors

Lead sponsors with the most studies (Lugano)
Lead sponsorStudiesRecruiting
Ente Ospedaliero Cantonale, Bellinzona139
University Hospital, Basel, Switzerland107
Insel Gruppe AG, University Hospital Bern76
Cardiocentro Ticino65
Merck Sharp & Dohme LLC62
Fondazione Epatocentro Ticino55
Hoffmann-La Roche50
University Hospital, Geneva54
AbbVie42
Christian Candrian44
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.